ArticleJournal of chemical information and modeling2026
Toward Imbalanced Molecular Property Regression: A Benchmark Study and Interval-Aware Mixture of Experts.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Molecular property prediction is a key task in AI-driven drug discovery, yet the prevalence and impact of label imbalances in molecular property regression remain poorly understood. Through a systematic benchmark of widely used molecular property data sets, we show that target values are often highly imbalanced and that prediction errors are consistently concentrated in sparsely represented regions of the label space. We further evaluate representative imbalance-learning approaches developed for general regression tasks and find that their effectiveness on molecular data sets is limited. To address this challenge, we propose interval-aware mixture-of-experts (IA-MoE), a plug-in framework that partitions the continuous target space into intervals and promotes expert specialization across different regions of the label distribution. IA-MoE can be seamlessly integrated with diverse molecular encoders without modifying their underlying architectures. Experiments on five molecular property benchmarks and four graph neural network backbones demonstrate that IA-MoE consistently improves the predictive performance in underrepresented regions while maintaining or improving overall accuracy. Our findings establish label imbalance as an important challenge in molecular property regression and highlight interval-aware expert learning as an effective strategy for addressing this challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.